Document Classification

Section Type: RESULTS

Text: In the 53 patients who received alpha-tocopherol there was a significant increase in plasma alpha-tocopherol concentrations (from 32. 66 + / - 13. 11 at baseline to 38. 31 + / - 13. 87 (mean + / - SD) micromol/l, p < 0. 01), a 40 % increase (compared with placebo patients) in circulating LDL-associated alpha-tocopherol (p < 0. 0001), and their LDL was less susceptible to ex vivo oxidation than that of the placebo group (lag phase 115. 3 + / - 28. 2 and 104. 4 + / - 15. 7 min respectively, p < 0. 02).